Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Roscovitine for Cell-Cycle Research Workflows
2026-09-24
Use Roscovitine (Seliciclib) to probe CDK-dependent cell-cycle behavior with reversible, dose-aware workflows—not as a substitute for radiotherapy or checkpoint blockade. This guide connects practical CDK experiments to recent tumor-immunity findings while clearly separating established evidence from testable combination hypotheses.
-
CPI-613 and Ferroptosis: Separate the Signals
2026-09-24
CPI-613, also known as 6,8-bis(benzylsulfanyl)octanoic acid, is a tool for probing mitochondrial carbon metabolism in cancer cells. This article connects its PDH and KGDH focus to mitochondrial calcium–ferroptosis research while showing how to distinguish metabolic disruption, apoptosis, and ferroptotic signaling without assuming they are the same mechanism.
-
Golgi-Tracker Green: From Label to Mechanism
2026-09-23
Golgi-Tracker Green enables selective live-cell Golgi apparatus imaging while preserving the dynamic biology of ceramide trafficking. This article explains how to distinguish organelle morphology from therapeutic mechanism and use the BODIPY FL-labeled C5-ceramide probe in better-designed assays.
-
Deferiprone at the Iron–Redox Interface
2026-09-22
Iron is not merely a biomarker of tissue injury; it can be a mechanistic control point linking oxidative stress, lipid peroxidation, apoptosis, and organ dysfunction. This thought-leadership article examines how Deferiprone can help translational researchers test that connection, using recent sickle cell rhabdomyolysis data to guide study design across kidney, cancer, cardiac, and neurovascular models.
-
HPF: Turning Reactive Oxygen Signals into Decisions
2026-09-22
Translational phototherapy research needs more than evidence that reactive oxygen species are present; it needs to identify which oxidative signals accompany therapeutic response. This article positions HPF (hydroxyphenyl fluorescein) as a selective, cell-compatible readout for highly reactive oxygen species and explains how it can strengthen mechanistic validation of multimodal phototherapy.
-
Mouse Tissue Lysis Kit (K1038) Workflow
2026-09-21
The Mouse Tissue Lysis Kit (K1038) prepares mouse tail, toe, or ear tissue lysates for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for molecular biology research and assay development, not diagnostic, clinical, or medical testing.
-
Adiponectin, TLR4, and Cognitive Deficits in Aged Rats
2026-09-21
The reference study uses pharmacological pathway modulation and multiple hippocampal readouts to show that adiponectin improves splenectomy-associated cognitive impairment in aged rats. Its findings connect reduced cognitive performance with TLR4/MyD88/NF-κB signaling, oxidative stress, and microglia-associated inflammation, while also highlighting important limits for translation.
-
SIRT4–GDH Control of Glutamine Metabolism in Liver Fibrosis
2026-09-20
The reference study identifies a metabolic checkpoint in which reduced SIRT4 activity permits GDH-dependent glutamine catabolism in hepatic stellate cells, increasing α-ketoglutarate production, proliferation, and fibrotic progression. Pharmacological GDH inhibition with EGCG and SIRT4 overexpression produced convergent antifibrotic effects, supporting glutamine metabolism as a mechanistically grounded research target.
-
7-AAD Viability Readouts for CD38 CAR-T Design
2026-09-19
A translational framework for using membrane-integrity measurements to interpret CD38 CAR-T cytotoxicity, fratricide, and affinity tuning with greater experimental precision.
-
Bestatin and Chemical Genetics of Jasmonate Signaling
2026-09-19
Zheng et al. established bestatin as a chemical activator of jasmonate signaling rather than merely an aminopeptidase inhibitor. By combining gene-expression profiling, pathway mutants, developmental assays, and resistant-mutant screening, the study identified a practical strategy for discovering previously unrecognized regulators of jasmonate responses in Arabidopsis.
-
Rapamycin (Sirolimus) mTOR Research Workflows
2026-09-18
Rapamycin (Sirolimus) provides a practical pharmacologic test of mTOR dependence across macrophage inflammation, cancer biology, lens epithelial models, and mitochondrial disease research. This guide connects dose design, pathway readouts, the EAAT2–mTORC1 axis, and troubleshooting strategies for more reproducible experiments.
-
Sodium Orthovanadate for Causal Signaling Assays
2026-09-17
Sodium Orthovanadate is more than a phosphorylation-preservation reagent: it can help distinguish phosphatase-sensitive signaling from downstream metabolic effects. This guide explains how to use Na3VO4 in insulin-signaling and protein tyrosine kinase assay workflows while controlling reversibility and metabolic confounding.
-
Live-Dead Cell Staining Kit for Biomaterial Assays
2026-09-17
Learn how the Live-Dead Cell Staining Kit converts membrane integrity and esterase activity into actionable evidence for evaluating hemostatic biomaterials. This article presents a mechanism-aware workflow for Calcein-AM Propidium Iodide staining, with practical guidance for microscopy, flow cytometry, and material-specific controls.
-
SmD2 Acetylation Links Splicing to PARP Sensitivity in HCC
2026-09-17
The reference study identifies SmD2, a core spliceosome component, as a regulatory link between acetylation, alternative splicing of BRCA1/FANC transcripts, DNA damage responses, and PARP inhibitor sensitivity in hepatocellular carcinoma. Its findings support a mechanistically guided combination of HDAC2-axis modulation with PARP inhibition, while also defining important limits for translating results from HCC models to broader cancer research.
-
EZ Cap™ Mouse IL-12 mRNA: Workflow Guide
2026-09-16
Build controlled cytokine-expression assays with capped, polyadenylated Mouse Interleukin-12 mRNA designed for efficient translation and reduced innate immune stimulation. This practical guide connects R1058 handling, delivery optimization, immune-cell readouts, and emerging circular RNA vaccine concepts without overstating what the evidence shows.